Studies have suggested that a defect downstream of insulin receptor substrate-1 phosphorylation or PI3K activation is responsible for insulin resistance in some patients with PCOS (Cheatham and Kahn, 1995; Saltiel and Kahn, 2001; Diamanti-Kandarakis and Dunaif, 2012). The gene discussed is IRS1; the disease is Insulin resistance.